A new marker for the early diagnosis of pancreatic cancer identified
Researchers from the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the IIBB-CSIC-IDIBAPS have led the study, published in t1
Researchers from the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the IIBB-CSIC-IDIBAPS have led the study, published in t1
The finding may make it possible to take therapeutic approaches that will increase the success rate of cognitive-behavioral therapy. This is the ther1
The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
Ten IDIBAPS groups are looking for candidates to apply for one of the 35 pre-doctoral scholarships offered by the INPhINIT Incoming program of the La1
Researchers at Hospital Clínic-IDIBAPS are leading the CIBERESUCICOVID project, which seeks to identify the risk and prognosis factors of patients wi1
Dr. Josep Baselga, an internationally renowned medical oncologist, died of this degenerative disease on 21 March 2021. The meeting was attended by Dr1
The study shows how the average life of the virus is drastically reduced, in transplanted patients and cell cultures alike.
The inhibition of this molecule, in addition to reducing the predisposition towards developing the disease, also reduces the alteration of the microb1
The researcher has received a runner’s-up prize in the Dr. Font Prize category, which recognises the best research articles published, with potential1
On Friday, 26 November, the dissemination seminar "Immunotherapy 2.0 in lymphoma: how to design personalized therapies" for patients and relatives wa1